Lasa Supergenerics Limited (BOM:540702)
India · Delayed Price · Currency is INR 5.39
0.00 (0.00%)
At close: Oct 5, 2026
Lasa Supergenerics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 63.56 | 251.41 | 1,424 | 1,043 | 1,296 | 1,371 |
Other Revenue | 1.64 | 1.33 | 27.81 | 0.99 | 8.62 | - |
| 65.2 | 252.74 | 1,452 | 1,044 | 1,304 | 1,371 | |
Revenue Growth | -95.23% | -82.60% | 39.06% | -19.93% | -4.88% | -32.24% |
Cost of Revenue | 99.88 | 242.22 | 1,069 | 752.18 | 1,075 | 897.68 |
Gross Profit | -34.69 | 10.52 | 383.53 | 292.17 | 229.09 | 473.59 |
Selling, General & Admin | 11.86 | 22.48 | 63.68 | 63.42 | 79.64 | 73.77 |
Other Operating Expenses | 34.36 | 59.74 | 227.06 | 206.1 | 187.62 | 207.24 |
Operating Expenses | 106.35 | 142.39 | 413.74 | 376.24 | 401.45 | 426.12 |
Operating Income | -141.04 | -131.87 | -30.2 | -84.08 | -172.36 | 47.47 |
Interest Expense | -4.98 | -4.17 | -27.83 | -19.32 | -41.54 | -0.25 |
Interest & Investment Income | - | 0.12 | 0.15 | - | 0.27 | 0.85 |
Currency Exchange Gain (Loss) | - | -0.31 | -0.71 | - | -16.42 | -7.3 |
Other Non Operating Income (Expenses) | 0 | -0.02 | -0.15 | 0 | -0.36 | -0.28 |
EBT Excluding Unusual Items | -146.02 | -136.24 | -58.75 | -103.39 | -230.41 | 40.5 |
Gain (Loss) on Sale of Assets | - | 0.54 | -0.56 | - | 6.72 | 0.94 |
Other Unusual Items | -9.41 | -210.38 | -134.53 | -87.73 | -198.97 | -102.83 |
Pretax Income | -155.42 | -346.08 | -193.83 | -191.12 | -422.65 | -61.39 |
Income Tax Expense | 10.07 | -5.17 | -46.26 | 26.18 | -36.44 | -8.08 |
Net Income | -165.5 | -340.9 | -147.57 | -217.31 | -386.21 | -53.31 |
Net Income to Common | -165.5 | -340.9 | -147.57 | -217.31 | -386.21 | -53.31 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 50 | 50 | 50 | 50 | 50 | 50 |
Shares Outstanding (Diluted) | 50 | 50 | 50 | 50 | 50 | 50 |
Shares Change | 0.21% | - | 0.06% | -0.06% | -0.39% | 23.66% |
EPS (Basic) | -3.30 | -6.80 | -2.95 | -4.34 | -7.71 | -1.06 |
EPS (Diluted) | -3.30 | -6.80 | -2.95 | -4.34 | -7.71 | -1.06 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -76.94 | -28.79 | 1.71 | -173 | 92.12 |
Free Cash Flow Per Share | - | -1.54 | -0.57 | 0.03 | -3.45 | 1.83 |
Dividend Per Share | - | - | - | - | - | 0.250 |
Dividend Growth | - | - | - | - | - | 0% |
Gross Margin | -53.20% | 4.16% | 26.41% | 27.98% | 17.56% | 34.54% |
Operating Margin | -216.32% | -52.18% | -2.08% | -8.05% | -13.21% | 3.46% |
Profit Margin | -253.83% | -134.88% | -10.16% | -20.81% | -29.61% | -3.89% |
Free Cash Flow Margin | - | -30.44% | -1.98% | 0.16% | -13.26% | 6.72% |
EBITDA | -96.48 | -72.08 | 92.41 | 22.53 | -38.17 | 192.58 |
EBITDA Margin | -147.97% | -28.52% | 6.36% | 2.16% | -2.93% | 14.04% |
D&A For EBITDA | 44.56 | 59.79 | 122.61 | 106.61 | 134.19 | 145.11 |
EBIT | -141.04 | -131.87 | -30.2 | -84.08 | -172.36 | 47.47 |
EBIT Margin | -216.32% | -52.18% | -2.08% | -8.05% | -13.21% | 3.46% |
Revenue as Reported | 65.2 | 253.41 | 1,475 | 1,044 | 1,314 | 1,374 |
Advertising Expenses | - | 0.14 | 0.42 | - | 3.24 | 0.34 |